Antithrombotic use and bleeding risk in patients with atrial fibrillation: findings from a multipayer analysis

To analyze administrative claims data from Medicaid, Medicare and commercial insurance sources to estimate stroke risk, bleeding risk, and the use of antithrombotic treatment in patients with atrial fibrillation (AF). Included patients were aged ≥18 years with a new or existing diagnosis of AF. Outc...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of comparative effectiveness research 2016-01, Vol.5 (1), p.39-48
Hauptverfasser:	Lang, Kathleen, Federico, Victoria, Patel, Aarti A, Munsell, Michael, Nelson, Winnie W, Owens, Gary, Mody, Samir H, Schein, Jeffery, Menzin, Joseph
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged anticoagulants Anticoagulants - adverse effects Anticoagulants - therapeutic use atrial fibrillation Atrial Fibrillation - drug therapy Female hemorrhage Hemorrhage - chemically induced Humans Insurance, Health Male Medicaid Medicare outcomes research Risk Assessment Risk Factors stroke Stroke - chemically induced United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!